亚毫西弗低剂量胸部CT中AI辅助分析COVID-19肺部受累的预后价值与可重复性:对临床试验样本量的启示
本研究为回顾性研究,纳入250例RT-PCR确诊的COVID-19患者,于入院时行亚毫西弗低剂量胸部CT,比较视觉与AI辅助分析肺部受累的预后价值和可重复性。AI辅助分析在预测不良结局(ICU入住或死亡)方面的AUC显著高于视觉分析,且观察者内和观察者间一致性更高、变异性更低。AI辅助分析检测肺部受累5%变化所需样本量为250例,视觉分析为1014例。
要点
- AI辅助半定量CT评分和定量肺部受累百分比的AUC均显著高于视觉分析(均P<0.001)。
- AI辅助观察者内和观察者间ICC均≥0.960,视觉分析均≥0.885,AI一致性更高。
- AI辅助定量肺部受累百分比的变异系数为17.2%,视觉分析为34.7%。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To compare the prognostic value and reproducibility of visual versus AI-assisted analysis of lung involvement on submillisievert low-dose chest CT in COVID-19 patients.
MATERIALS AND METHODS: This was a HIPAA-compliant, institutional review board-approved retrospective study. From March 15 to June 1, 2020, 250 RT-PCR confirmed COVID-19 patients were studied with low-dose chest CT at admission. Visual and AI-assisted analysis of lung involvement was performed by using a semi-quantitative CT score and a quantitative percentage of lung involvement. Adverse outcome was defined as intensive care unit (ICU) admission or death. Cox regression analysis, Kaplan-Meier curves, and cross-validated receiver operating characteristic curve with area under the curve (AUROC) analysis was performed to compare model performance. Intraclass correlation coefficients (ICCs) and Bland- Altman analysis was used to assess intra- and interreader reproducibility.
RESULTS: Adverse outcome occurred in 39 patients (11 deaths, 28 ICU admissions). AUC values from AI-assisted analysis were significantly higher than those from visual analysis for both semi-quantitative CT scores and percentages of lung involvement (all P<0.001). Intrareader and interreader agreement rates were significantly higher for AI-assisted analysis than visual analysis (all ICC ≥0.960 versus ≥0.885). AI-assisted variability for quantitative percentage of lung involvement was 17.2% (coefficient of variation) versus 34.7% for visual analysis. The sample size to detect a 5% change in lung involvement with 90% power and an α error of 0.05 was 250 patients with AI-assisted analysis and 1014 patients with visual analysis.
CONCLUSION: AI-assisted analysis of lung involvement on submillisievert low-dose chest CT outperformed conventional visual analysis in predicting outcome in COVID-19 patients while reducing CT variability. Lung involvement on chest CT could be used as a reliable metric in future clinical trials.
引用
- Gieraerts C, Dangis A, Janssen L, et al. Prognostic Value and Reproducibility of AI-assisted Analysis of Lung Involvement in COVID-19 on Low-Dose Submillisievert Chest CT: Sample Size Implications for Clinical Trials. Radiol Cardiothorac Imaging. 2020. PMID: 33778634. doi:10.1148/ryct.2020200441
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。